Erythroleukemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Erythroleukemia Classification and external resources | |
| Erythroleukemia: Nucleated Red Cells and Erythroblasts Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | C94.0 |
| ICD-9 | 207.0 |
| ICD-O: | M9840/3 |
| OMIM | 133180 |
| eMedicine | med/729 |
| MeSH | D004915 |
|
WikiDoc Resources for Erythroleukemia | |
|
Articles | |
|---|---|
|
Most recent articles on Erythroleukemia Most cited articles on Erythroleukemia | |
|
Media | |
|
Powerpoint slides on Erythroleukemia | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Erythroleukemia at Clinical Trials.gov Trial results on Erythroleukemia Clinical Trials on Erythroleukemia at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Erythroleukemia NICE Guidance on Erythroleukemia
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Erythroleukemia Discussion groups on Erythroleukemia Patient Handouts on Erythroleukemia Directions to Hospitals Treating Erythroleukemia Risk calculators and risk factors for Erythroleukemia
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Erythroleukemia | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Erythroleukemia (or "acute Di Guglielmo syndrome") is a rare form of acute myeloid leukemia where the myeloproliferation is of erythrocyte precursors.
It is defined at type "M6" under the FAB classification.[1]
Types
It can be classified as follows:
- M6a; Erythroid/Myeloid
- M6b; Pure Erythroid Malignancy
Criteria for diagnosis of M6
M6a
50% or more of all nucleated bone marrow cells are erythroblasts, Dyserythropoiesis is prominent and 30% or more of the remaining cells (non- erythroid) are myeloblasts.
M6b ( Pure Erythroid Malignancy )
In rare cases the erythroid lineage is the only obvious components of an acute leukemia; a myeloblast component is not apparent. The erythroid component consists predominantly or exclusively of proerythroblasts and early basophilic erythroblasts. These cells may constitute 90% or more of the marrow elements. Despite this lack of myeloblast, these cases should be considered acute leukemias. In WHO proposal the blastic leukeimas that are limited to the erythroid series are designated pure erythroid malignancy.
References
Kowal-Vern A, Mazzella FM, Cotelingam JD, Shrit MA, Rector JT, Schumacher HR (2000). "Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases". Am. J. Hematol. 65 (1): 5-13. PMID 10936857.
External links
WikiDoc Research Resources for Erythroleukemia (Click show to right to view) | |
|---|---|
| Articles on Erythroleukemia | Most recent articles on Erythroleukemia • Most cited articles on Erythroleukemia • Review articles on Erythroleukemia • Articles on Erythroleukemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Erythroleukemia | Powerpoint slides on Erythroleukemia • Images of Erythroleukemia • Photos of Erythroleukemia • Podcasts & MP3s on Erythroleukemia • Videos on Erythroleukemia |
| Evidence Based Medicine Regarding Erythroleukemia | Cochrane Collaboration on Erythroleukemia • Bandolier on Erythroleukemia • TRIP on Erythroleukemia |
| Cost Effectiveness of Erythroleukemia | Cost Effectiveness of Erythroleukemia |
| Clinical Trials Involving Erythroleukemia | Ongoing Trials on Erythroleukemia at Clinical Trials.gov • Trial results on Erythroleukemia • Clinical Trials on Erythroleukemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Erythroleukemia | US National Guidelines Clearinghouse on Erythroleukemia • NICE Guidance on Erythroleukemia • NHS PRODIGY Guidance • FDA on Erythroleukemia • CDC on Erythroleukemia |
| Textbook Information on Erythroleukemia | Books and Textbook Information on Erythroleukemia |
| Pharmacology Resources on Erythroleukemia | Dosing of Erythroleukemia • Drug interactions with Erythroleukemia • Side effects of Erythroleukemia • Allergic reactions to Erythroleukemia • Overdose information on Erythroleukemia • Carcinogenicity information on Erythroleukemia • Erythroleukemia in pregnancy • Pharmacokinetics of Erythroleukemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Erythroleukemia | Genetics of Erythroleukemia • Pharmacogenomics of Erythroleukemia • Proteomics of Erythroleukemia |
| Newstories on Erythroleukemia | Erythroleukemia in the news • Be alerted to news on Erythroleukemia • News trends on Erythroleukemia |
| Commentary on Erythroleukemia | Blogs on Erythroleukemia |
| Patient Resources on Erythroleukemia | Patient resources on Erythroleukemia • Discussion groups on Erythroleukemia • Patient Handouts on Erythroleukemia • Directions to Hospitals Treating Erythroleukemia • Risk calculators and risk factors for Erythroleukemia |
| Healthcare Provider Resources on Erythroleukemia | Symptoms of Erythroleukemia • Causes & Risk Factors for Erythroleukemia • Diagnostic studies for Erythroleukemia • Treatment of Erythroleukemia |
| Continuing Medical Education (CME) Programs on Erythroleukemia | CME Programs on Erythroleukemia |
| International Resources on Erythroleukemia | Erythroleukemia en Espanol • Erythroleukemia en Francais |
| Business Resources on Erythroleukemia | Erythroleukemia in the Marketplace • Patents on Erythroleukemia |
| Informatics Resources on Erythroleukemia | List of terms related to Erythroleukemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

